Wiley Bros. Aintree Capital, LLC Senseonics Holdings, Inc. Transaction History
Wiley Bros. Aintree Capital, LLC
- $9.13 Billion
- Q1 2025
A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Senseonics Holdings, Inc. stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 219,805 shares of SENS stock, worth $116,496. This represents 0.0% of its overall portfolio holdings.
Number of Shares
219,805
Previous 70,062
213.73%
Holding current value
$116,496
Previous $36,000
302.78%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding SENS
# of Institutions
157Shares Held
83.3MCall Options Held
564KPut Options Held
490K-
Vanguard Group Inc Valley Forge, PA25.7MShares$13.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.32MShares$4.41 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA6.87MShares$3.64 Million0.0% of portfolio
-
State Street Corp Boston, MA5.63MShares$2.98 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny4.73MShares$2.51 Million0.01% of portfolio
About Senseonics Holdings, Inc.
- Ticker SENS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 465,447,008
- Market Cap $247M
- Description
- Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...